Operating Income Summary of Virbac SA

Virbac SA's latest annual operating income in 2023 was 184.87 Million EUR , down -4.2% from previous year.
Virbac SA's latest quarterly operating income in 2024 Q2 was 54.26 Million EUR , down 0.0% from previous quarter.
Virbac SA reported an annual operating income of 179.51 Million EUR in 2022, up 7.09% from previous year.
Virbac SA reported an annual operating income of 167.62 Million EUR in 2021, down -9.71% from previous year.
Virbac SA reported a quarterly operating income of 54.26 Million EUR for 2024 Q2, down 0.0% from previous quarter.
Virbac SA reported a quarterly operating income of 171.98 Million EUR for 2023 FY, down -4.2% from previous quarter.

Annual Operating Income Chart of Virbac SA (2023 - 2002)

Historical Annual Operating Income of Virbac SA (2023 - 2002)

Year	Operating Income	Operating Income Growth
2023	184.87 Million EUR	-4.2%
2022	179.51 Million EUR	7.09%
2021	167.62 Million EUR	-9.71%
2020	185.66 Million EUR	89.51%
2019	97.97 Million EUR	50.74%
2018	64.99 Million EUR	11.96%
2017	58.04 Million EUR	-15.89%
2016	69.01 Million EUR	99.99%
2015	34.5 Million EUR	-68.36%
2014	109.06 Million EUR	4.8%
2013	104.06 Million EUR	5.99%
2012	98.18 Million EUR	13.88%
2011	86.21 Million EUR	-1.74%
2010	87.74 Million EUR	50.53%
2009	58.29 Million EUR	7.1%
2008	54.42 Million EUR	5.37%
2007	51.65 Million EUR	29.73%
2006	39.81 Million EUR	24.07%
2005	32.08 Million EUR	13.58%
2004	28.25 Million EUR	5.26%
2003	26.84 Million EUR	-26.9%
2002	36.71 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	54.26 Million EUR	43.8%
2024 Q2	54.26 Million EUR	0.0%
2023 FY	171.98 Million EUR	-4.2%
2023 Q2	100.44 Million EUR	86.25%
2023 Q3	39.11 Million EUR	-61.06%
2023 Q4	37.73 Million EUR	-3.53%
2023 Q1	53.92 Million EUR	-14.5%
2022 Q1	57.67 Million EUR	-6.78%
2022 Q2	110.25 Million EUR	91.16%
2022 Q3	34.16 Million EUR	-69.01%
2022 Q4	63.07 Million EUR	84.61%
2022 FY	179.51 Million EUR	7.09%
2021 Q4	61.87 Million EUR	85.07%
2021 FY	167.62 Million EUR	-9.71%
2021 Q2	98.22 Million EUR	91.89%
2021 Q1	51.18 Million EUR	27.42%
2021 Q3	33.43 Million EUR	-65.96%
2020 FY	185.66 Million EUR	89.51%
2020 Q2	73.48 Million EUR	86.33%
2020 Q1	39.43 Million EUR	-13.4%
2020 Q4	40.17 Million EUR	87.26%
2020 Q3	21.45 Million EUR	-70.81%
2019 Q2	28.69 Million EUR	0.0%
2019 Q4	45.54 Million EUR	92.02%
2019 FY	97.97 Million EUR	50.74%
2019 Q3	23.71 Million EUR	-17.35%
2019 Q1	28.69 Million EUR	52.99%
2018 Q3	18.75 Million EUR	-0.02%
2018 FY	64.99 Million EUR	11.96%
2018 Q2	18.76 Million EUR	0.0%
2018 Q1	18.76 Million EUR	15.71%
2018 Q4	18.75 Million EUR	0.0%
2017 Q3	16.21 Million EUR	-0.23%
2017 Q2	16.25 Million EUR	0.0%
2017 Q4	16.21 Million EUR	0.0%
2017 FY	58.04 Million EUR	-15.89%
2017 Q1	16.25 Million EUR	-6.36%
2016 Q4	17.35 Million EUR	0.0%
2016 Q1	15.8 Million EUR	51.9%
2016 FY	69.01 Million EUR	99.99%
2016 Q3	17.35 Million EUR	9.82%
2016 Q2	15.8 Million EUR	0.0%
2015 Q2	9.03 Million EUR	0.0%
2015 FY	34.5 Million EUR	-68.36%
2015 Q4	10.4 Million EUR	0.0%
2015 Q3	10.4 Million EUR	15.14%
2015 Q1	9.03 Million EUR	-69.61%
2014 Q1	25.05 Million EUR	1.83%
2014 FY	109.06 Million EUR	4.8%
2014 Q3	29.73 Million EUR	18.67%
2014 Q4	29.73 Million EUR	0.0%
2014 Q2	25.05 Million EUR	0.0%
2013 Q1	28.11 Million EUR	0.0%
2013 FY	104.06 Million EUR	5.99%
2013 Q3	24.6 Million EUR	-12.48%
2013 Q2	28.11 Million EUR	0.0%
2013 Q4	24.6 Million EUR	0.0%
2012 FY	98.18 Million EUR	13.88%
2011 FY	86.21 Million EUR	-1.74%
2010 FY	87.74 Million EUR	50.53%
2009 FY	58.29 Million EUR	7.1%
2008 FY	54.42 Million EUR	5.37%
2007 FY	51.65 Million EUR	29.73%
2006 FY	39.81 Million EUR	24.07%
2005 FY	32.08 Million EUR	13.58%
2004 FY	28.25 Million EUR	5.26%
2003 FY	26.84 Million EUR	-26.9%
2002 FY	36.71 Million EUR	0.0%

Peer Operating Income Comparison of Virbac SA

Name	Operating Income	Operating Income Difference
AstraZeneca PLC	8.19 Billion USD	97.743%
Bristol-Myers Squibb Company PFD CONV 2	17.24 Billion USD	98.928%
CSPC Pharmaceutical Group Limited	7.01 Billion USD	97.365%
Clarus Therapeutics Holdings, Inc.	-39.73 Million USD	565.308%
Novartis AG	9.76 Billion USD	98.108%
PT Kalbe Farma Tbk.	3625.13 Billion USD	99.995%

Global Stocks Search

Virbac SA (VRBCF)

Operating Income Summary of Virbac SA

Annual Operating Income Chart of Virbac SA (2023 - 2002)

Historical Annual Operating Income of Virbac SA (2023 - 2002)

Peer Operating Income Comparison of Virbac SA